Adenovirus-mediated gene transfer of CTLA4Ig to liver allografts results in prolonged survival and local T-cell anergy.
Olthoff
K M
KM
Department of Surgery, University of Pennsylvania, Philadelphia 19104, USA.
Da Chen
X
X
Gelman
A
A
Turka
L
L
Shaked
A
A
D000069594:Abatacept; D000256:Adenoviridae; D000818:Animals; D015703:Antigens, CD; D000943:Antigens, Differentiation / Q000096:biosynthesis / Q000276:immunology*; D060908:CTLA-4 Antigen; D017635:Clonal Anergy; D005822:Genetic Vectors; D006085:Graft Survival; D018796:Immunoconjugates; D007165:Immunosuppression Therapy / Q000379:methods; D016031:Liver Transplantation / Q000276:immunology* / Q000502:physiology; D051379:Mice; D051381:Rats; D011912:Rats, Inbred ACI; D011917:Rats, Inbred Lew; D011994:Recombinant Proteins / Q000096:biosynthesis / Q000276:immunology; D013601:T-Lymphocytes / Q000276:immunology*; D013997:Time Factors; D014162:Transfection
D015703:Antigens, CD; D000943:Antigens, Differentiation; D060908:CTLA-4 Antigen; C556707:Ctla4 protein, mouse; D018796:Immunoconjugates; D011994:Recombinant Proteins; D000069594:Abatacept